Nikol Vácová Selected Research

Neoplasms (Cancer)

12/2016	Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model.
10/2016	The use of Zymosan A and bacteria anchored to tumor cells for effective cancer immunotherapy: B16-F10 murine melanoma model.
1/2014	The use of anchored agonists of phagocytic receptors for cancer immunotherapy: B16-F10 murine melanoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nikol Vácová Research Topics

Disease

3	Neoplasms (Cancer) 12/2016 - 01/2014
3	Melanoma (Melanoma, Malignant) 12/2016 - 01/2014

Drug/Important Bio-Agent (IBA)

2	LigandsIBA 12/2016 - 01/2014
1	MannansIBA 12/2016
1	Toll-Like Receptor AgonistsIBA 12/2016
1	resiquimodIBA 12/2016
1	N-Formylmethionine Leucyl-PhenylalanineIBA 12/2016
1	ZymosanIBA 10/2016
1	laminaranIBA 01/2014
1	leucyl-phenylalanineIBA 01/2014
1	Mannose (D-Mannose)IBA 01/2014

Therapy/Procedure

3	Immunotherapy 12/2016 - 01/2014
1	Transplantation 12/2016
1	Therapeutics 10/2016